Advertisement
Screener

Aevi Genomic Medicine, Inc. Research and Development Expense

Aevi Genomic Medicine, Inc. Research and Development Expense

Aevi Genomic Medicine, Inc. reported Research and Development Expense of $2.50 million for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-14.

Discontinued › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2019-11-14

  • Aevi Genomic Medicine, Inc. research and development expense for the quarter ending 2019-09-30 was $2.50M, a 51.24% decline year-over-year.
  • Aevi Genomic Medicine, Inc. research and development expense for the quarter ending 2019-03-31 was $1.33M, a 48.57% decline year-over-year.
  • Aevi Genomic Medicine, Inc. research and development expense for the quarter ending 2018-12-31 was -$10.32M, a 296.12% decline year-over-year.
  • Aevi Genomic Medicine, Inc. research and development expense for the quarter ending 2018-09-30 was $5.13M, a 18.64% decline year-over-year.
  • Aevi Genomic Medicine, Inc. research and development expense for fiscal 2018 was $7.11M, a 8.60% decline from fiscal 2017.
  • Aevi Genomic Medicine, Inc. research and development expense for fiscal 2017 was $7.78M, a 72.56% decline from fiscal 2016.
  • Aevi Genomic Medicine, Inc. research and development expense for fiscal 2016 was $28.36M, a 83.61% increase from fiscal 2015.
  • Aevi Genomic Medicine, Inc. research and development expense for fiscal 2015 was $15.44M, a 87.13% increase from fiscal 2014.
Period endResearch and Development Expense 1 monthResearch and Development Expense 3 monthResearch and Development Expense 6 monthResearch and Development Expense 9 monthResearch and Development Expense 12 monthResearch and Development Expense 12 month as first filedResearch and Development Expense 137 monthResearch and Development Expense 140 monthResearch and Development Expense 143 monthResearch and Development Expense 146 monthResearch and Development Expense 149 monthResearch and Development Expense 152 monthResearch and Development Expense 155 monthResearch and Development Expense 158 monthResearch and Development Expense 161 monthResearch and Development Expense 164 monthResearch and Development Expense 167 monthResearch and Development Expense 170 month
2019-09-30$2.50M
10-Q · filed 2019-11-14
$7.90M
10-Q · filed 2019-11-14
2019-03-31$1.33M
10-Q · filed 2019-05-14
-$8.99M
derived: sum of 2 quarters · filed 2019-05-14
-$3.87M
derived: sum of 3 quarters · filed 2019-11-14
2018-12-31-$10.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29
-$5.20M
derived: sum of 2 quarters · filed 2019-11-14
$7.11M
10-K · filed 2019-03-29
2018-09-30$5.13M
10-Q · filed 2019-11-14
$17.43M
10-Q · filed 2019-11-14
2018-03-31$2.59M
10-Q · filed 2019-05-14
$7.85M
derived: sum of 2 quarters · filed 2019-05-14
$14.15M
derived: sum of 3 quarters · filed 2019-05-14
$19.82M
derived: sum of 4 quarters · filed 2019-05-14
2017-12-31$5.26M
10-K · filed 2018-03-13
$11.56M
derived: sum of 2 quarters · filed 2018-03-13
$17.23M
derived: sum of 3 quarters · filed 2018-03-13
$7.78M
10-K · filed 2019-03-29
$25.18M
10-K · filed 2018-03-13
2017-09-30$6.30M
10-K · filed 2018-03-13
$11.97M
derived: sum of 2 quarters · filed 2018-03-13
$19.91M
derived: sum of 3 quarters · filed 2018-03-13
$25.05M
derived: sum of 4 quarters · filed 2018-03-13
2017-06-30$5.67M
10-K · filed 2018-03-13
$13.61M
derived: sum of 2 quarters · filed 2018-03-13
$18.75M
derived: sum of 3 quarters · filed 2018-03-13
$26.28M
derived: sum of 4 quarters · filed 2018-03-13
2017-03-31$7.95M
10-K · filed 2018-03-13
$13.08M
derived: sum of 2 quarters · filed 2018-03-13
$20.61M
derived: sum of 3 quarters · filed 2018-03-13
$29.35M
derived: sum of 4 quarters · filed 2018-03-13
2016-12-31$5.13M
10-K · filed 2018-03-13
$12.66M
derived: sum of 2 quarters · filed 2018-03-13
$21.41M
derived: sum of 3 quarters · filed 2018-03-13
$28.36M
10-K · filed 2018-03-13
2016-09-30$7.53M
10-K · filed 2018-03-13
$16.27M
derived: sum of 2 quarters · filed 2018-03-13
$23.22M
10-Q · filed 2016-11-03
$27.54M
derived: sum of 4 quarters · filed 2018-03-13
2016-06-30$8.74M
10-K · filed 2018-03-13
$15.69M
10-Q · filed 2016-08-04
$20.01M
derived: sum of 3 quarters · filed 2018-03-13
$24.21M
derived: sum of 4 quarters · filed 2018-03-13
2016-03-31$6.95M
10-K · filed 2018-03-13
$11.27M
derived: sum of 2 quarters · filed 2018-03-13
$15.47M
derived: sum of 3 quarters · filed 2018-03-13
$18.49M
derived: sum of 4 quarters · filed 2018-03-13
2015-12-31$4.31M
10-K · filed 2017-03-09
$8.52M
derived: sum of 2 quarters · filed 2017-03-09
$11.54M
derived: sum of 3 quarters · filed 2017-03-09
$15.44M
10-K · filed 2018-03-13
2015-09-30$4.20M
10-K · filed 2017-03-09
$7.23M
derived: sum of 2 quarters · filed 2017-03-09
$11.13M
10-Q · filed 2016-11-03
$14.90M
derived: sum of 4 quarters · filed 2017-03-09
2015-06-30$3.03M
10-K · filed 2017-03-09
$6.93M
10-Q · filed 2016-08-04
$10.70M
derived: sum of 3 quarters · filed 2017-03-09
$12.27M
derived: sum of 4 quarters · filed 2017-03-09
2015-03-31$3.90M
10-K · filed 2017-03-09
$7.67M
derived: sum of 2 quarters · filed 2017-03-09
$9.24M
derived: sum of 3 quarters · filed 2017-03-09
$10.01M
derived: sum of 4 quarters · filed 2017-03-09
2014-12-31$3.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09
$5.34M
derived: sum of 2 quarters · filed 2017-03-09
$6.11M
derived: sum of 3 quarters · filed 2017-03-09
$8.25M
10-K · filed 2017-03-09
2014-09-30$1.56M
10-Q · filed 2015-10-22
$2.34M
derived: sum of 2 quarters · filed 2015-10-22
$4.48M
10-Q · filed 2015-10-22
$6.55M
derived: sum of 4 quarters · filed 2016-02-26
2014-06-30$773.00K
10-Q · filed 2015-08-10
$2.92M
10-Q · filed 2015-08-10
$4.98M
derived: sum of 3 quarters · filed 2016-02-26
$7.33M
derived: sum of 4 quarters · filed 2016-02-26
2014-03-31$2.14M
10-Q · filed 2014-05-08
$4.21M
derived: sum of 2 quarters · filed 2016-02-26
$6.55M
derived: sum of 3 quarters · filed 2016-02-26
$7.41M
derived: sum of 4 quarters · filed 2016-02-26
$38.71M
10-Q · filed 2014-05-08
2013-12-31$2.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26
$4.41M
derived: sum of 2 quarters · filed 2016-02-26
$5.27M
derived: sum of 3 quarters · filed 2016-02-26
$7.30M
10-K · filed 2016-02-26
$36.57M
10-K · filed 2014-02-20
2013-09-30$2.34M
10-Q · filed 2014-10-15
$3.20M
derived: sum of 2 quarters · filed 2014-10-15
$5.23M
10-Q · filed 2014-10-15
$7.30M
derived: sum of 4 quarters · filed 2015-02-13
$34.50M
10-Q · filed 2013-11-07
2013-06-30$855.00K
10-Q · filed 2014-07-16
$2.89M
10-Q · filed 2014-07-16
$4.96M
derived: sum of 3 quarters · filed 2015-02-13
$6.57M
derived: sum of 4 quarters · filed 2015-02-13
$32.16M
10-Q · filed 2013-08-06
2013-03-31$2.03M
10-Q · filed 2014-05-08
$4.11M
derived: sum of 2 quarters · filed 2015-02-13
$5.72M
derived: sum of 3 quarters · filed 2015-02-13
$6.89M
derived: sum of 4 quarters · filed 2015-02-13
$31.30M
10-Q · filed 2013-05-09
2012-12-31$2.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13
$3.69M
derived: sum of 2 quarters · filed 2015-02-13
$4.86M
derived: sum of 3 quarters · filed 2015-02-13
$5.43M
10-K · filed 2015-02-13
$29.27M
10-K · filed 2013-03-14
2012-09-30$1.61M
10-Q · filed 2013-11-07
$2.79M
derived: sum of 2 quarters · filed 2013-11-07
$3.36M
10-Q · filed 2013-11-07
$4.84M
derived: sum of 4 quarters · filed 2014-02-20
$27.19M
10-Q · filed 2012-11-14
2012-06-30$1.18M
10-Q · filed 2013-08-06
$1.75M
10-Q · filed 2013-08-06
$3.23M
derived: sum of 3 quarters · filed 2014-02-20
$4.58M
derived: sum of 4 quarters · filed 2014-02-20
$25.58M
10-Q/A · filed 2012-09-04
2012-03-31$570.00K
10-Q · filed 2013-05-09
$2.05M
derived: sum of 2 quarters · filed 2014-02-20
$3.41M
derived: sum of 3 quarters · filed 2014-02-20
$4.45M
derived: sum of 4 quarters · filed 2014-02-20
$24.41M
10-Q · filed 2012-05-14
2011-12-31$1.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20
$2.84M
derived: sum of 2 quarters · filed 2014-02-20
$3.88M
derived: sum of 3 quarters · filed 2014-02-20
$5.05M
10-K · filed 2014-02-20
$23.84M
10-K · filed 2012-03-06
2011-09-30$1.35M
10-Q · filed 2012-11-14
$2.39M
derived: sum of 2 quarters · filed 2012-11-14
$3.57M
10-Q · filed 2012-11-14
$2.59M
derived: sum of 4 quarters · filed 2013-03-14
$22.35M
10-Q · filed 2011-11-10
2011-06-30$1.04M
10-Q/A · filed 2012-09-04
$2.21M
10-Q/A · filed 2012-09-04
$1.23M
derived: sum of 3 quarters · filed 2013-03-14
$1.67M
derived: sum of 4 quarters · filed 2013-03-14
$21.00M
10-Q/A · filed 2011-09-08
2011-04-30$200.00K
10-K · filed 2013-03-14
2011-03-31$1.17M
10-Q · filed 2012-05-14
$193.00K
derived: sum of 2 quarters · filed 2013-03-14
$628.00K
derived: sum of 3 quarters · filed 2013-03-14
$1.03M
derived: sum of 4 quarters · filed 2013-03-14
2010-12-31-$981.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14
-$546.00K
derived: sum of 2 quarters · filed 2013-03-14
-$147.00K
derived: sum of 3 quarters · filed 2013-03-14
$150.00K
10-K · filed 2013-03-14
$1.53M
10-K · filed 2012-03-06
2010-09-30$435.00K
10-Q · filed 2011-11-10
$834.00K
derived: sum of 2 quarters · filed 2011-11-10
$1.13M
10-Q · filed 2011-11-10
2010-06-30$399.00K
10-Q/A · filed 2011-09-08
$696.00K
10-Q/A · filed 2011-09-08
2007-12-31$50.00K
10-K · filed 2013-03-14